Cholangiocarcinoma (National Cancer Centre of Singapore, Nat Genet 2013)

Summary

Cholangiocarcinoma (National Cancer Centre of Singapore, Nat Genet 2013) is a study catalogued by cBioPortal DataHub under the cancer-type code chol. EvidenceHelix groups it with liver, bile duct and gallbladder studies.

Study description

Whole exome sequencing of 15 cholangiocarcinoma cases.

Text as published in the source's study metadata.

Citation & PubMed

Chan-on et al. Nat Genet 2013

Linked PubMed records: PMID 24185513

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

chol_nccs_2013

Short name

Cholangiocarcinoma (NCCS)

Source cancer-type code

chol

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Chan-on et al. Nat Genet 2013

• PubMed record 24185513 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Cholangiocarcinoma (ICGC, Cancer Discov 2017)

  Whole-exome sequencing and Targeted/Exome sequencing of 489 Cholangiocarcinoma samples from 10 countries.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (National University of Singapore, Nat Genet 2012)

  Exome Sequencing for Opisthorchis viverrini-related cholangiocarcinoma in 8 O.viverrini-related tumors and matched normal tissue.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Intrahepatic Cholangiocarcinoma (JHU, Nat Genet 2013)

  Exome sequencing of tumor/normal pairs from 32 intrahepatic cholangiocarcinoma cases and 8 gall bladder carcinoma cases.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (MSK, Clin Cancer Res 2018)

  Targeted sequencing (MSK-IMPACT) of 195 tumor samples (194 with matched normals) from 192 cholangiocarcinoma patients.

  Liver, bile duct and gallbladderMSK studiesSource code cholPubMed 1

• Cholangiocarcinoma (TCGA, Firehose Legacy)

  TCGA Cholangiocarcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/CHOL/20160128/). Previously known as TCGA Provisional.

  Liver, bile duct and gallbladderTCGA Firehose LegacySource code chol

• Cholangiocarcinoma (TCGA, PanCancer Atlas)

  Cholangiocarcinoma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pancanceratlas/panca…

  Liver, bile duct and gallbladderTCGA PanCancer AtlasSource code cholPubMed 11

• Ampullary Carcinoma (Baylor College of Medicine, Cell Reports 2016)

  Exome sequencing analysis of 160 cancers arising in the periampullary region, 62 of these clearly arising from either the bile duct (n = 44) or the duodenum (n = 18) and 98 for which the epithelium of origin could not…

  Liver, bile duct and gallbladderOther published and consortium studiesSource code ampcaPubMed 1

• Combined Hepatocellular and Intrahepatic Cholangiocarcinoma (Peking University, Cancer Cell 2019)

  Whole-exome sequencing of 121 combined hepatocellular and intrahepatic cholangiocarcinoma (cHCC-ICC) patients with matched normal pairs (whole-genome sequenced samples are not included here).

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccihchPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.